Skip to main content

Astrana Health, Inc.

corporate_fare Company Profile

Astrana Health, Inc.

ASTH·NASDAQ·Trade & Services·CIK 0001083446

Astrana is a physician-centric, technology-powered healthcare company that operates an integrated healthcare delivery platform. The company enables providers to participate in value-based care arrangements, helping them deliver accessible, high-quality, and cost-effective care. Astrana, along with its affiliated physician groups, consolidated subsidiaries, and VIEs, provides coordinated outcome-based care to patients covered by private or public insurance, including Medicare, Medicaid, and HMOs, with a small portion of revenue from non-insured patients. Astrana offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians, physician and specialist extenders, and hospitalists. As of December 31, 2025, Astrana’s integrated health network comprised more than 20,000 contracted physicians and was responsible for coordinating value-based care for approximately 1.6 million patients. The company operates through three reportable segments: Care Partners, Care Delivery, and Care Enablement. The Care Partners segment focuses on building and managing high-quality provider networks by partnering with and investing in provider partners to achieve coordinated care delivery. Astrana's common stock is listed on The Nasdaq Stock Market LLC under the symbol "ASTH."

Astrana Health, Inc. (NASDAQ:ASTH) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 18 items for ASTH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 8/10. Across its 18 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for ASTH spans 10-Q, 8-K, DEF 14A, S-3ASR.

Recent high-impact activity:

  • Astrana Q3 10-Q: Record $1.02B Revenue, But Material Weakness Still Unremediated
  • Q3 Revenue Tops $1B as Net Income Jumps 1,782%, FY Guidance Narrowed
  • Astrana Health Discloses Material Cybersecurity Incident Involving Unauthorized Data Access
  • Astrana Health Q2 Revenue Jumps 49% to $972.5M, but Lingering Material Weakness Tempers the Quarter
  • Astrana Health Q2 Revenue Misses, But EPS Crushes Estimates and Guidance Raised

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$3.18B
Net Income
$22.49M
Diluted EPS
$0.46
Op. Cash Flow
$114.6M
Free Cash Flow
$104.49M
Operating Income
$78.53M
Cash & Equivalents
$429.47M
Total Debt
$1.04B
Debt / Equity
1.33×
Net Margin
0.7%
Shares Outstanding
48.89M sh
Source: 10-K · filed 2026-03-12 · accession 0001193125-26-103128

Short Interest & Short Volume

12.28 days to cover

FINRA reported short interest of 2,994,790 shares in ASTH as of the October 30, 2026 settlement, a 0.5% decrease from the prior period — about 12.3 days to cover at its recent average daily volume. On November 20, 2026, 62.2% of ASTH volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,994,790 shares as of October 30, 2026
Change vs prior period▼ 0.5%
Days to cover12.28 at avg daily volume of 243,777
Daily short volume (FINRA facilities)62.2% of 128,446 shares on November 20, 2026
5-day average short volume73.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with A →
$28.9
52-week range · as of 2026-11-06 $18.08 – $51.6
Market cap
$1.43B
Volume
441K (1.2× avg)
3-mo avg 365.6K
Live data · 2026-11-22 03:44 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ASTH - Latest Insights

ASTH
Nov 06, 2026, 6:00 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $39.01
Real-time Price: $28.90 info
Change: -$10.11 (-26%) info
Market Cap: $1.434B info
ASTH
Nov 05, 2026, 4:05 PM EST
Source: PR Newswire
Importance Score:
8
Price at Filing: $39.01
Real-time Price: $28.90 info
Change: -$10.11 (-26%) info
Market Cap: $1.434B info
ASTH
Sep 23, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $35.11
Real-time Price: $28.90 info
Change: -$6.21 (-18%) info
Market Cap: $1.434B info
ASTH
Aug 10, 2026, 5:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $37.47
Real-time Price: $28.90 info
Change: -$8.57 (-23%) info
Market Cap: $1.434B info
ASTH
Aug 06, 2026, 4:39 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $33.70
Real-time Price: $28.90 info
Change: -$4.80 (-14%) info
Market Cap: $1.434B info
ASTH
Aug 06, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $34.13
Real-time Price: $28.90 info
Change: -$5.23 (-15%) info
Market Cap: $1.434B info
ASTH
Jul 13, 2026, 8:13 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $46.87
Real-time Price: $28.90 info
Change: -$17.97 (-38%) info
Market Cap: $1.434B info
ASTH
Jul 13, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $46.87
Real-time Price: $28.90 info
Change: -$17.97 (-38%) info
Market Cap: $1.434B info
ASTH
Jun 10, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $38.73
Real-time Price: $28.90 info
Change: -$9.83 (-25%) info
Market Cap: $1.434B info
ASTH
May 08, 2026, 6:01 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $35.21
Real-time Price: $28.90 info
Change: -$6.31 (-18%) info
Market Cap: $1.434B info
ASTH
May 07, 2026, 4:27 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $33.00
Real-time Price: $28.90 info
Change: -$4.10 (-12%) info
Market Cap: $1.434B info
ASTH
May 07, 2026, 4:12 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $35.00
Real-time Price: $28.90 info
Change: -$6.10 (-17%) info
Market Cap: $1.434B info
ASTH
Apr 17, 2026, 6:01 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $30.60
Real-time Price: $28.90 info
Change: -$1.70 (-6%) info
Market Cap: $1.434B info
ASTH
Mar 30, 2026, 7:39 PM EDT
Filing Type: S-3ASR
Importance Score:
7
Price at Filing: $24.25
Real-time Price: $28.90 info
Change: +$4.65 (+19%) info
Market Cap: $1.434B info
ASTH
Mar 30, 2026, 5:43 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $24.34
Real-time Price: $28.90 info
Change: +$4.56 (+19%) info
Market Cap: $1.434B info
ASTH
Mar 12, 2026, 8:11 AM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $23.91
Real-time Price: $28.90 info
Change: +$4.99 (+21%) info
Market Cap: $1.434B info
ASTH
Mar 02, 2026, 7:11 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $21.50
Real-time Price: $28.90 info
Change: +$7.40 (+34%) info
Market Cap: $1.434B info
ASTH
Jan 12, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $29.21
Real-time Price: $28.90 info
Change: -$0.310 (-1%) info
Market Cap: $1.434B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets